Take a fresh look at your lifestyle.

WHO dọrọ aka ná ntị megide iji ọgwụ abụọ eme ihe maka COVID-19 na-adịghị njọ.

Kamila Bello dere ya na bekee.

0 523

WHO dọrọ aka ná ntị megide iji ọgwụ abụọ eme ihe maka COVID-19 na-adịghị njọ.

Out Ahụike uwa bu (WHO), dụrụ ndị ọrịa nwere obere okwu COVID-19 dị nro ma ọ bụ na-agafeghị oke megide iji ọgwụ antidepressant, fluvoxamine, na ọgwụ gout colchicine.

WHO kwuru na nkwupụta na, ihe ngosi ugbu a akwadoghị iji colchicine na-agwọ COVID-19 na-adịghị njọ, na-agbakwunye na e kwesịghị iji fluvoxamine na-enweghị ule ụlọ ọgwụ.

Dị ka akụkọ sitere n’aka otu WHO Guideline Development Group si kwuo, ndụmọdụ ahụ dị mkpa n’ihi enweghị ihe akaebe zuru oke nke nsonaazụ dị mma site na iji ọgwụ ọjọọ eme ihe na ihe ọjọọ ha nwere.

Akuko a, nke otu ndi okachamara mba uwa gbakotara na British Medical Journal, kwuru na o nweghi ihe akwadoro maka ma ogwu di n’ime ndi oria nwere oke oria ma obu nke di oke egwu.

“A na-ejikarị fluvoxamine na colchicine eme ihe, ọgwụ ndị na-adịghị ọnụ nke natara mmasị dị ukwuu dị ka ọgwụgwọ COVID-19 nwere ike n’oge ọrịa ahụ.

“Otú ọ dị, ndụmọdụ ndị a na-enye taa megide iji ha eme ihe na-egosipụta ejighị n’aka na-aga n’ihu banyere otú ọgwụ ndị ahụ si emetụta ahụ.

Leave a Reply

Your email address will not be published. Required fields are marked *